Evidence mapPaperPMID 41044789Full record

ReviewChinese medicine2025

Therapeutic potential of traditional Chinese medicine and mechanisms for the treatment of type 2 diabetes mellitus.

Miao Wang, Qing Yang, Ye Li, Yang Zhao, Junbo Zou, Fei Luan, Xiujuan Peng, Zhuangzhuang Huang, Feng Liu

Abstract readReview
In one paragraph

Review in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The role of PYY in improving insulin resistance.Frontiers in endocrinology · 2026
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miao WangSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Qing YangSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Ye LiSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Yang ZhaoSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Junbo ZouSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Fei LuanSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Xiujuan PengKey Laboratory of Chemical Substances and Biological Effects of Traditional Chinese Medicine, Shaanxi Institute of International Trade & Commerce, Xi'an, 712046, People's Republic of China.
Zhuangzhuang HuangKey Laboratory of Chemical Substances and Biological Effects of Traditional Chinese Medicine, Shaanxi Institute of International Trade & Commerce, Xi'an, 712046, People's Republic of China. huangstrong@163.com.
Feng LiuSchool of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China. liufeng1720@163.com.

Funding

General Project of National Natural Science Foundation of China 82274095Shaanxi Provincial Administration of Traditional Chinese Medicine Research Project 2021-ZZ-ZY005Shaanxi Provincial Department of Education Youth Innovation Team Project 22JP005Shaanxi Provincial Department of Science and Technology Key R&D Program Project 2022SF-355Shaanxi Provincial Key Industry Innovation Chain Project 2022ZDLSF05-09
6 · The paper itself

Abstract

Diabetes, a chronic metabolic non-communicable disease, has become prevalent worldwide. Its prevalence is increasing at an alarming rate, and the affected population is becoming increasingly younger, posing a serious threat to both individual health and social well-being. Notably, type 2 diabetes mellitus (T2DM) accounts for more than 90% of all diabetes cases, a statistic that underscores its dominant position in the disease burden. Despite substantial progress in the field of diabetes treatment, existing diabetes medications still fail to fully address the complex and pressing clinical needs of patients. Therefore, the development of new therapeutic drugs for T2DM is of crucial significance. Traditional Chinese medicine (TCM) has shown significant potential in alleviating the symptoms of T2DM and improving patients' quality of life, providing an effective complementary approach to conventional treatments. This study systematically clarifies and reviews the pathogenesis of T2DM from multiple dimensions, including inflammation, oxidative stress, ferroptosis, pyroptosis, necroptosis, autophagy, and gut microbiota. It also examines and summarizes TCM compound formulations and their main active ingredients that can improve the disease, and elucidates the disease-improving effects of these TCM ingredients targeting the aforementioned mechanisms. Studies have shown that TCM plays an important role in improving T2DM by targeting key mechanisms such as insulin resistance, β-cell damage, and glucose-lipid metabolism disorders. This not only provides valuable ideas and reference basis for researchers in endocrine basic research, pharmacologists, and clinicians to develop TCM with low toxicity and side effects but also opens up new research directions for the treatment of T2DM and lays a theoretical foundation for new drug development.

Indexed as

Active ingredientsChinese herbal formulaPathological mechanismTraditional Chinese medicineType 2 diabetes mellitus

Identifiers

PMID41044789
PMCPMC12495626

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.